Medical supply firm Medline targets $39.5 billion valuation in blockbuster IPO (Dec. 8)
Medical supply firm Medline targets $39.5 billion valuation in blockbuster IPO (Dec. 8)
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
LEO
HYPE
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
LEO
HYPE
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
LEO
HYPE
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
LEO
HYPE
ADA
Institutional stablecoin use triples: Why B2B payments are crypto's new frontier
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse Articles
Medical supply firm Medline targets $39.5 billion valuation in blockbuster IPO (Dec. 8)
Shares saw their first record close since December 2024, helping support the continued reign of the "Magnificent Seven."
Shares of cannabis stocks continued their rally Tuesday, after President Donald Trump a day earlier said he was "very strongly" weighing an executive order...
DBV Technologies stock soars after positive Phase 3 trial results
Investors can expect asset write-downs and new plans from auto makers that leaned a little too hard into the trend. Curiously, that shouldn't be a headwind...
E.W. Scripps stock falls after board rejects Sinclair's $7 per share offer
Google's new deal could serve as a blueprint for the energy industry.
Growth may mellow out, but the long-term prospects remain strong.
Renowned TV host Jim Cramer issued a "Sell" rating on a prominent AI infrastructure stock that has been under pressure in recent weeks, despite several bul...
After an active morning Tuesday, bitcoin flattened out in afternoon trading around the $87,500 area, up 2% over the past 24 hours.
After a four-year investigation into whether its lending and borrowing operations constituted unregistered securities offerings, Aave has had the SEC probe...
With markets hovering around all-time highs, now may be a difficult time for some growth investors to step into specific names. After all, valuations have...